Revolutionizing Virology: AI-Generated Bacteriophages

Artificial intelligence is proving to be a powerful tool in the realm of genetic design, pushing the boundaries of what we thought was possible. Recently, researchers revealed that AI has not only been capable of generating basic sequences but has successfully constructed entire working genomes of viruses.

On September 17, a paper published on bioRxiv.org detailed how two advanced AI models were utilized to create blueprints for 16 different viruses targeting Escherichia coli in laboratory settings. The breakthrough suggests that these AI-designed bacteriophages could play a pivotal role in developing new therapies capable of combating challenging microbial infections, although the research is still awaiting peer review.

This achievement marks a significant milestone. “It’s the first time that AI has successfully generated an entire genome,” says Brian Hie, a computational biologist at Stanford University and the Arc Institute in Palo Alto, California. While the debate about whether viruses qualify as living organisms continues, this research is a noteworthy advancement towards the potential application of AI in designing living beings.

Historically, AI has been leveraged to develop individual genes and proteins. However, the intricate challenge of constructing a complete genomic framework is substantially more complex, as it demands the coordination of numerous genes and proteins, explains Hie.

In their recent study, Hie and his colleagues harnessed two of their proprietary AI models, dubbed Evo 1 and Evo 2, to attempt the creation of genomes for bacteriophages, which are viruses that specifically infect bacteria. These models were trained using billions of sequences comprising the basic units of genetic material—A, C, G, and T—culled from existing phage genomes. The researchers leveraged the well-characterized bacteriophage known as ΦX174, which made history in 1977 as the first DNA-based genome ever sequenced, as a benchmark for AI-driven genome design.

With its well-documented genetic profile, ΦX174 provided a relevant reference point to evaluate the novelty of mutations generated by the AI. Importantly, working with bacteriophages like ΦX174 posed no risk to human health, leading the team to avoid training their models on examples of viral pathogens due to safety concerns.

After generating around 300 potential phage genomes, 16 were identified that produced viable viruses with the ability to infect E. coli. Notably, some of these AI-generated phages exhibited a more rapid lethality compared to the traditional ΦX174. Furthermore, while ΦX174 struggled against certain resistant strains of E. coli, combinations of AI-generated phages adapted quickly to overcome these barriers, showcasing the potential for evolving phage therapies.

The implications of these findings highlight the potential of AI in developing targeted phage therapies, particularly important in the fight against antibiotic-resistant bacterial infections. As Kimberly Davis, a microbiologist at Johns Hopkins Bloomberg School of Public Health, stated, “The need to find a phage that targets the bacterial strain would be very urgent,” emphasizing the rapid phage generation capabilities presented by AI.

Davis also stresses the necessity for stringent controls over the use of AI-generated phages, including comprehensive testing to ensure that these phages do not disrupt the balance of beneficial microbial communities.

Ultimately, the goal is to produce phages that target only harmful bacteria without affecting the beneficial strains that play a crucial role in human health, Hie notes. Furthermore, AI could facilitate microbial manufacturing processes, enhancing the production of antibiotics or fostering microbes capable of degrading plastic waste.

Looking ahead, AI’s capacity to unravel complex genomes holds promise for unlocking new treatments for intricate diseases. Given that the human genome exceeds half a million times the length of ΦX174’s genome, Hie acknowledges that there is much work ahead in this transformative field.